Feedback activation of HER3 attenuates response to EGFR inhibitors in colon cancer cells. (Oncotarget, 2016)

(untitled) - Bosch-Vilaró, A; Jacobs, B; Pomella, V; Abbasi Asbagh, L; Kirkland, R; Michel, J; Singh, S; Liu, X; Kim, P; Weitsman, G; Barber, P; Vojnovic, B; et al.